The present study aimed to identify blood-based inflammatory biomarkers that would help investigate the underlying pathogenesis in vestibular neuritis (VN) using a proximity extension assay (PEA).
Methods
In this single-center prospective study, we enrolled both a cross-sectional (acute VN vs normal controls) and a longitudinal (acute phase vs recovery phase) cohorts. We quantified 92 plasma inflammatory proteins using the Olink PEA and identified differentially expressed proteins (DEPs) in each cohort using t-tests. The clinical utility and predictive value of each DEP were evaluated using the Pearson correlation test and receiver operating characteristic (ROC) curve analysis, respectively.
Results
In the cross-sectional cohort, there were 17 DEPs identified between acute VN (n = 35) and normal controls (n = 35), of which Flt3L was the only downregulated DEP that showed longitudinal changes congruent with clinical disease activity in the longitudinal cohort (n = 18). The correlation analysis revealed that the expression level of CXCL5 was significantly related to the absolute gain and gain asymmetry of the horizontal vestibulo-ocular reflex, while five DEPs (OSM, Flt3L, IFN-γ, MCP-1, and uPA) were negatively correlated with the hospitalization period. ROC curves showed that CXCL1 and Flt3L were upregulated and downregulated DEPs with high predictive values, respectively.
Conclusions
This study shows that the high-throughput PEA technology can be used to identify blood-based inflammatory biomarkers for VN. Our findings highlight the potential value of Flt3L and CXCL1/CXCL5 as objective VN markers that may correlate with disease activity.
ArbusowVStruppMWasickyR, et al.Detection of herpes simplex virus type 1 in human vestibular nuclei. Neurology2000; 55(6): 880–882.
7.
ArbusowVDerfussTHeldK, et al.Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. J Med Virol2010; 82(11): 1917–1920.
8.
ArbusowVSchulzPStruppM, et al.Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol1999; 46(3): 416–419.
9.
HimmeleinSLindemannASinicinaI, et al.Differential involvement during latent Herpes simplex virus 1 infection of the superior and inferior divisions of the vestibular ganglia: implications for vestibular neuritis. J Virol2017; 91(14): e00331.
10.
RujescuDHartmannAMGieglingI, et al.Genome-wide association study in vestibular neuritis: involvement of the host factor for HSV-1 replication. Front Neurol2018; 9: 591.
11.
RujescuDHerrlingMHartmannAM, et al.High-risk allele for Herpes labialis severity at the IFNL3/4 locus is associated with vestibular neuritis. Front Neurol2020; 11: 570638.
AronsonJKFernerRE. Biomarkers-A general review. Curr Protoc Pharmacol2017; 76: 9.23.1–9.23.17.
14.
NutiDBiaginiCSalerniL, et al.Use of mammalian inner ear antigens for the diagnosis of autoimmune sudden loss of vestibular function. Acta Otolaryngol Suppl2002; 548: 34–37.
15.
AvalloneESchmittHLilliG, et al.A potential serological biomarker for inner ear pathologies: OTOLIN-1. Acta Otorhinolaryngol Ital2022; 42(4): 364–371.
16.
KassnerSSSchottlerSBonaterraGA, et al.Proinflammatory activation of peripheral blood mononuclear cells in patients with vestibular neuritis. Audiol Neurootol2011; 16(4): 242–247.
17.
BummPSchlimokG. T-lymphocyte subpopulations and HLA-DR antigens in patients with Bell's palsy, hearing loss, neuronitis vestibularis, and Ménière's disease. Eur Arch Otorhinolaryngol1994; 70(5): S447–S448.
18.
AssarssonELundbergMHolmquistG, et al.Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One2014; 9(4): e95192.
19.
JabbariEWoodsideJGuoT, et al.Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry2019; 90(7): 768–773.
20.
GawdeSAgasingABhattN, et al.Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL. Mult Scler Relat Disord2022; 63: 103922.
21.
WeiQLiJZhaoC, et al.Blood-based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: a prospective cohort study. CNS Neurosci Ther2024; 30(6): e14811.
22.
WieskeLMichaelMRIn 't VeldSGJG, et al.Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry2024; 95(7): 595–604.
23.
HochbergYBenjaminiY. More powerful procedures for multiple significance testing. Stat Med1990; 9(7): 811–818.
24.
SzklarczykDGableALNastouKC, et al.The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res2021; 49(D1): D605–D612.
25.
HoffmannJAKafatosFCJanewayCA, et al.Phylogenetic perspectives in innate immunity. Science1999; 284(5418): 1313–1318.
26.
SteinmanRM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol1991; 9: 271–296.
27.
Wodnar-FilipowiczA. Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow. News Physiol Sci2003; 18: 247–251.
28.
MaraskovskyEDaroERouxE, et al.In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood2000; 96(3): 878–884.
29.
WaskowCLiuKDarrasse-JèzeG, et al.The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol2008; 9(6): 676–683.
30.
MaraskovskyEBraselKTeepeM, et al.Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med1996; 184(5): 1953–1962.
31.
ShawSGMaungAASteptoeRJ, et al.Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J Immunol1998; 161(6): 2817–2824.
32.
SmithJRThackrayAMBujdosoR. Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells. Immunology2001; 102(3): 352–358.
33.
EidenschenkCCrozatKKrebsP, et al.Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells. Proc Natl Acad Sci U S A2010; 107(21): 9759–9764.
34.
MomenilandiMLévyRSobrinoS, et al.FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. Cell2024; 187(11): 2817–2837.
35.
LiMGaoYYangL, et al.Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Front Immunol2022; 13: 1024333.
36.
LiMHLuYSunFF, et al.Transforming growth factor β as a possible independent factor in chronic hepatitis B. Arch Virol2021; 166(7): 1853–1858.
37.
DemoulinSRoncaratiPDelvenneP, et al.Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34(+) hematopoietic progenitor cells: use of interleukin-3. Exp Hematol2012; 40(4): 268–278.
38.
AtanleyEvan Drunen Littel-van den HurkS. Future considerations for dendritic cell immunotherapy against chronic viral infections. Expet Rev Clin Immunol2014; 10(6): 801–813.
39.
ZhouCGaoYDingP, et al.The role of CXCL family members in different diseases. Cell Death Discov2023; 9(1): 212.
40.
MetgudmathVVMetgudmathVBBabuE. Neutrophil-to-lymphocyte ratio: a shunned entity as a novelty in diagnosing peripheral vestibular disorders. Indian J Otolaryngol Head Neck Surg2025; 77(1): 96–99.
41.
OhEHRheeJKShinJH, et al.Neutrophil-mediated immune response as a possible mechanism of acute unilateral vestibulopathy. J Vestib Res2020; 30(6): 363–374.
42.
OhEHKimHSChoiSY, et al.Clinical significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute unilateral vestibulopathy. J Clin Neurol2024; 20(3): 315–320.
43.
ChungJHLimJJeongJH, et al.The significance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in vestibular neuritis. Laryngoscope2015; 125(7): E257–E261.
44.
RawatSVratiSBanerjeeA. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspect Med2021; 81: 100996.
45.
PapayannopoulosV. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol2018; 18(2): 134–147.
46.
BardoelBWKennyEFSollbergerG, et al.The balancing act of neutrophils. Cell Host Microbe2014; 15(5): 526–536.
47.
ChenZTrappBD. Microglia and neuroprotection. J Neurochem2016; 136(Suppl 1): 10–17.
48.
LiuYFLiangJJNgTK, et al.CXCL5/CXCR2 modulates inflammation-mediated neural repair after optic nerve injury. Exp Neurol2021; 341: 113711.
49.
MarouaneEEl-MahmoudiNRastoldoG, et al.Sensorimotor rehabilitation promotes vestibular compensation in a rodent model of acute peripheral vestibulopathy by promoting microgliogenesis in the deafferented vestibular nuclei. Cells2021; 10(12): 3377.
50.
RastoldoGMarouaneEEl-MahmoudiN, et al.L-Thyroxine improves vestibular compensation in a rat model of acute peripheral vestibulopathy: cellular and behavioral aspects. Cells2022; 11(4): 684.
51.
WuJLuGZhengZ, et al.The efficacy of early rehabilitation in enhancing vestibular compensation in mice with unilateral vestibular neurectomy by promoting cellular proliferation and glial reaction. Neuroscience2025; 567: 182–194.
52.
TricoJMarouaneEWatabeI, et al.Pro-histaminergic drug restores balance, promotes microgliogenesis and modulates neuroinflammation after vestibular injury. Eur J Pharmacol2025; 998: 177600.
53.
FlookMFrejoLGallego-MartinezA, et al.Differential proinflammatory signature in vestibular migraine and meniere disease. Front Immunol2019; 10: 1229.
